AV
ARCH Venture Partners
Venture Capital · Founded 1986 · Chicago, United States
ARCH Venture Partners’ biggest current holdings.
The most valuable companies ARCH Venture Partners still holds — unicorns and thoroughbreds it has backed, ordered by Dealroom’s latest valuation. Companies that have been acquired or gone public are in Exits instead. Where a cap table names ARCH Venture Partners directly, the stake and its estimated value are shown too.
-
1
Prometheus
—
$41.0B
—
-
2
Altos Labs
—
$6.3B
—
-
3
Aledade
7.5%
$3.5B
$262M
-
4
Xaira Therapeutics
—
$2.7B
—
-
5
Resilience
—
$2.5B
—
-
6
Treeline Biosciences
—
$2.1B
—
-
7
Areteia Therapeutics
—
$1.8B
—
-
8
Insitro
—
$1.6B
—
-
9
Oratomic
—
$1.5B
—
-
10
SonderMind Wellness Centers
—
$1.1B
—
Estimated value = ARCH Venture Partners’ disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →
ARCH Venture Partners’ biggest exits.
Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from ARCH Venture Partners’ transaction record.
Where ARCH Venture Partners’ portfolio is concentrated.
Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 251 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.
-
USA327
-
China12
-
UK5
-
Ireland3
-
Cuba2
-
Germany2
-
Israel2
-
Singapore2
-
Sweden2
-
Canada1
-
Denmark1
-
Iceland1
-
Health268
-
Semiconductors20
-
Enterprise Software17
-
Energy12
-
Media10
-
Food7
-
Education3
-
Fashion3
-
Fintech3
-
Home Living3
-
Robotics3
-
Security3
-
Series A149
-
Series B+75
-
Seed23
-
Late Growth147
-
Breakout Stage107
-
Early Growth90
-
Mature21
Inside ARCH Venture Partners’ portfolio.
The 60 highest-funded portfolio companies, of 251 tracked.
Pr
In
PfAlRe
EQ
GRTrXa
Pa
Sa
GeAl
Go
Vi
Mi
MaIn
Ar
Ne
Ka
Ly
Me
Li
EG
Ge
OlAr
Br
CS
Sa
Vi
Ve
Me
Be
As
De
Er
Ik
Pr
So
Sy
Se
Ju
To
Ar
SiOr
De
Pa
Or
Ch
CR
Sy
Ag
Bo
Ra
AI
Ru
TwWhere ARCH Venture Partners’ portfolio founders come from.
178 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.
-
United States164
-
United Kingdom3
-
China2
-
Australia1
-
France1
-
India1
-
Portugal1
-
Massachusetts Institute of Technology18
-
Harvard University15
-
Stanford University8
-
Harvard Medical School7
-
Harvard Business School5
-
University of California, Berkeley5
-
Yale University4
-
Columbia University3
-
Duke University3
-
Northwestern University3
-
Genentech5
-
Massachusetts Institute of Technology5
-
Merck & Co.5
-
Stanford University5
-
Biogen4
-
Broad Institute4
-
Harvard Medical School4
-
Massachusetts General Hospital4
-
MyoKardia4
-
Novartis4
Similar investors.
Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.
Key people at ARCH Venture Partners.
